Funding opportunities are available across a variety of fields and specialties, ranging from asthma and allergies to HIV to treatment for mental disorders.
New Senior Vice President for Health Sciences and CEO for U of U Health Bob Carter, MD, PhD, talks about who he is, his leadership values, and future vision.
Researchers, doctors, and community members came together to improve understanding of the full health, social, and even environmental impacts of these medications.
A combination of human genetic analysis and research in flies identified the protective gene, which could ultimately lead to better therapies for people with the seizure disorder.
Researchers in the College of Nursing are developing practical solutions and fostering community engagement to address the social factors outside of health care that impact health and well-being.
Along his path from curious fourth grader to visionary dean, Wayne Samuelson, MD, embraced each opportunity to serve, teach, and lead while staying true to his compassionate approach to medicine.
There may be up to a tenfold difference in risk for infants who are currently treated identically under clinical guidelines. The analysis is an important step toward more personalized care.
We wish Michael Good a fond farewell and a warm welcome to Bob Carter, while celebrating national recognition for clinical care and communications, a new periodontics residency program, and more.
Since 2019, the University of Utah has been developing the world’s most advanced “neuroprosthesis” — an artificial upper arm and hand that is controlled by the user’s thoughts. Named the...
Much of health sciences research involves seeing the unseen: the genetic and bioinformatic data that underlies human health and disease. At the University of Utah, generating that data involves top-quality...
Health sciences research has more than doubled in size over the past 12 years, a trajectory that highlights U of U Health as a destination for leading faculty, learners, and...
Before 1993, women were rarely included in clinical trials. Today, the medical field still doesn’t know how well many drugs and devices work for women.
Funding opportunities are available across a variety of fields and specialties, ranging from NIDDK research areas to Alzheimer's disease to gene-based therapies, and more.
Researchers led by U biomedical engineer Jan Kubanek developed a way to deliver therapeutic levels of drugs to the brain in ways that maximize their benefit and minimize risks.
A conversation with Mark Rapaport, MD, CEO of Huntsman Mental Health Institute, offers insights into his path to psychiatry, lessons learned, and the purpose he finds in his work.
